πŸ‡ΊπŸ‡Έ FDA
Patent

US 11459357

Polymyxin compounds

granted A61KA61K38/00A61K38/12

Quick answer

US patent 11459357 (Polymyxin compounds) held by SPERO THERAPEUTICS, INC. expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SPERO THERAPEUTICS, INC.
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K38/12